CONTENTS PUBLICATIONS IN 2009

5 downloads 75 Views 645KB Size Report
Surg Today 39(6):476-480,2009. 19. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer. Shibahara ...
CONTENTS PUBLICATIONS IN 2009 消化管 1.

Page1

The triangulating stapling technique for cervical esophagogastric anastomosis after esophagectomy. Toh Y, et al. Surg Today 39(3):201-206,2009

2.

The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Toh Y, et al. Clin Exp Metastasis. 26(3):215-227,2009

3.

Evaluation of the feasibility and safety of immediate extubation after esophagectomy with extended radical three-field lymph node dissection for thoracic esophageal cancers. Toh Y, et al. Esophagus 6(3):167-172,2009

4.

Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery. Watanabe A, et al. Surg Today 38(5):404-412,2008

5.

Phase II Study of biweekly Docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Kakeji Y, et al. Oncology 77(1):49-52,2009

6.

Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications. Morita M, et al. Anticancer Res. 29(7):2555-2562,2009

7.

Clinical features of primary small cell carcinoma of the thoracic esophagus: a retrospective analysis of 12 surgically resected cases. Sadanaga N, et al. Esophagus 6(3):161-165,2009

8.

Clinicopathological characteristics of recurrence more than 10 years after surgery in patients with breast carcinoma. Takeuchi H, et al. Anticancer Res. 29(8):3445-3448,2009

CONTENTS PUBLICATIONS IN 2009 消化管 9.

Page2

Transcervical superior mediastinal lymph node dissection combined with transhiatal lower esophageal dissection before transthoracic esophagectomy: a safe approach for salvage esophagectomy. Watanabe M, et al. J Am Coll Surg. 208(4):e7-e9

10.

Clinical significance of Smac/DIABLO expression in colorectal cancer. Endo K, et al. Oncol Rep. 21(2):351-355,2009

11.

Reduced expression of catenin subtypes is a potential indicator of unfavorable prognosis in esophageal squamous cell carcinoma. Nozoe T, et al. Mol Med Rep. 2:353-357,2009

12.

The long-term outcome of atomic bomb survivors with gastric carcinoma. Yamamoto M. et al. J Surg Oncol. 100(7):594-597,2009

13.

Chemosensitivity and survival in gastric cancer patients with microsatellite instability. Oki E, et al. Ann Surg Oncol. 16(9):2510-2515,2009

14.

Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer. Oki E, et al. World J Gastroenterol. 15(20):2520-2525,2009

15.

The difference in p53 mutations between cancers of the upper and lower gastrointestinal tract. Oki E, et al. Digestion 79(Sup1):33-39,2009

16.

Transient elastography for the prediction of oxaliplatin- associated liver injury in colon cancer patients: a preliminary analysis. Oki E, et al. J Gastrointest Cancer 39(1-4):82-85,2008

CONTENTS PUBLICATIONS IN 2009 消化管 17.

Page3

Huge gastric carcinoma showing an exophytic growth pattern: a case report and review of the literature. Oki E, et al. J Gastrointest Cancer 39(1-4):42-45,2008

18.

Postoperative management using intensive patient-controlled epidural analgesia and early rehabilitation after an esophagectomy. Saeki H, et al. Surg Today 39(6):476-480,2009

19.

Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer. Shibahara K, et al. Anticancer Res. 28(3B):1779-1783,2008

20.

Laparoscopic treatment for splenosis: report of a case. Hashimoto K, et al. Surg Today 39(12):1098-1102,2009

21.

Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis. Taniguchi K, et al. PLoS One. 4(5):e5467(1-11),2009

22.

Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth. Taniguchi K, et al. Cancer Sci. 100(9):1648-1654,2009

23.

Successful treatment of acute esophageal necrosis caused by intrathoracic gastric volvulus: Report of a case. Matsumoto N, et al. Surg Today 39(12):1068-1072,2009

24.

Endotracheal surgery for leiomyoma of the trachea. Sugiyama M, et al. Ann Thorac Cardiovasc Surg. 15(3):206-208,2009

CONTENTS PUBLICATIONS IN 2009 消化管 25.

Page4

Salvage Hyperthermo-chemotherapy for Local Recurrence of Cervical Esophageal Cancer after Definitive Chemoradiotherapy : A Case Report. Sugiyama M, et al. Thermal Medicine 25(2):53-58,2009

CONTENTS PUBLICATIONS IN 2009 乳腺 26.

Page5

Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients. Sagara Y, et al. Breast Cancer Epub ahead of print (1-6)

CONTENTS PUBLICATIONS IN 2009 肝臓・移植 27.

Page6

Pancreatogastrostomy with an elastic purse-string suture around the gastric orifice after pancreatoduodenectomy. Nishizaki T, et al. Surg Today 39(6):548-551,2009

28.

Early outcome following hepatic resection in patients older than 80 years of age. Shirabe K, et al. World J Surg. 33(9):1927-1932,2009

29.

Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion. Shirabe K, et al. World J Gastroenterol. 15(21):2632-2637,2009

30.

Predictors of microscopic portal vein invasion by hepatocellular carcinoma: measurement of portal perfusion defect area ratio. Shirabe K, et al. J Gastroenterol Hepatol. 24(8):1431-1436,2009

31.

High dorsal resection for recurrent hepatocellular carcinoma originating in the caudate lobe. Utsunomiya T, et al. Surg Today 39(9):829-832,2009

32.

Decreased intratumoral arteries reflect portal tract destruction and aggressive characteristics in intrahepatic cholangiocarcinoma. Aishima S, et al. Histopathology

33.

54(4):452-461,2009

Tumor ablation therapy of liver cancers with an open magnetic resonance imaging-based navigation system. Maeda T, et al. Surg Endosc. 23(5):1048-1053,2009

34.

Phase I/II study of the lipiodolization using DDP-H (CDDP powder; IA-call○R ) in patients with unresectable hepatocellular carcinoma.Cancer Chemother Pharmacol. Yamashita Y, et al. Epub ahead of print (1-7)

CONTENTS PUBLICATIONS IN 2009 肝臓・移植 35.

Page7

Phase II Trial of Gemcitabine Combined with 5-fluorouracil and Cisplatin (GFP) Chemotherapy in Patients with Advanced Biliary Tree Cancers. Yamashita Y, et al. Jpn J Ciln Oncol. 40(1):24-28,2010

36.

Comparison of enteral nutrition with combined enteral and parenteral nutrition in post-pancreaticoduodenectomy patients: a pilot study. Nagata S, et al. Nutr J. 8:24(1-8),2009

37.

Coexistence of mucinous cystic neoplasm occurring in the head of the pancreas with annular pancreas: report of a case. Ijichi H, et al. Surg Today 39(10):897-900,2009

38.

Long-Term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas. Itoh S, et al. Ann Surg Oncol. 16(12):3299-3307,2009

39.

Fascin expression in progression and prognosis of hepatocellular carcinoma. Iguchi T, et al. J Surg Oncol. 100(7):575-579,2009

40.

Both fibrous capsule formation and extracapsular penetration are powerful predictors of poor survival in human hepatocellular carcinoma: a histological assessment of 365 patients in Japan. Iguchi T, et al. Ann Surg Oncol. 16(9):2539-2546,2009

41.

A comprehensive analysis of immunohistochemical cholangiocarcinoma using the survival tree model.

studies

in

intrahepatic

Iguchi T, et al. Oncology 76(4):293-300,2009 42.

Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis. Iguchi T, et al. Hum Pathol. 40(2):174-180,2009

CONTENTS PUBLICATIONS IN 2009 肝臓・移植 43.

Page8

Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C. Sanefuji K, et al. J Surg Oncol. 99(1):32-37,2009

44.

Impact of amino acid substitutions in the core region of HCV on multistep hepatocarcinogenesis. Fukuhara T, et al. Hepatol Res. Epub ahead of print (1-8)

45.

Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Taketomi A, et al. Transplantation 87(4):531-537,2009

46.

Donor risk in adult-to-adult living donor liver transplantation: impact of left lobe graft. Taketomi A, et al. Transplantation 87(3):445-450,2009

47.

Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Ikegami T, et al. Transplantation 88(3):303-307,2009

48.

Hypersplenism after living donor liver transplantation. Ikegami T, et al. Hepato-Gastroenterol. 56(91-92):778-782,2009

49.

Potential risk in using hepatic veins of a native liver for reconstructing accessory veins in right lobe living donor graft. Ikegami T, et al. Transplantation

50.

88(1):143-144,2009

The use of autologous vena cava patch graft for reconstructing multiple outflow orifices in right hemiliver living donor graft. Ikegami T, et al. Transpl Int. 22(8):853-855,2009

CONTENTS PUBLICATIONS IN 2009 肝臓・移植 51.

Page9

The changes of the medial right lobe, transplanted with left lobe liver graft from living donors. Ikegami T, et al. Transplantation

52.

87(5):698-703,2009

Rapid normalization transplantation.

of

portopulmonary

hypertension

after

living

donor

liver

Sugimachi K, et al. Transplant Proc. 41(5):1976-1978,20090 53.

Chronological improvement of portal flow in the remnant right lobe liver of a left lobe living donor. Sugimachi K, et al. Transplantation 88(4):598-600,2009

54.

Recurrent familial hypobetalipoproteinemia-induced nonalcoholic fatty liver disease after living donor liver transplantation. Harada N, et al. Liver Transplant. 15(7):806-809,2009

55.

Proctocolectomy for colon cancer associated with ulcerative colitis a few months after living donor liver transplantation for primary sclerosing cholangitis: report of a case. Fukuhara T, et al. Surg Today 39(1):59-63,2009

56.

Congestion of the donor remnant right liver after extended left lobe donation. Fukuhara T, et al. Transpl Int. 22(8):837-844,2009

57.

De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation. Morita K, et al. Liver Transplant. 15(11):1412-1416,2009

CONTENTS PUBLICATIONS IN 2009 脾・門脈 58.

Laparoscopic splenectomy may be a superior supportive patients with hypersplenism.

Page10

intervention for cirrhotic

Tomikawa M, et al. J Gastroenterol Hepatol. Epub ahead of print (1-6) 59.

Technical standardization of laparoscopic splenectomy harmonized with hand-assisted laparoscopic surgery for patients with liver cirrhosis and hypersplenism. Kawanaka H, et al. J Hepatobiliary Pancreat Surg. 16(6):749-757,2009

60.

Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism. Akahoshi T, et al. Surg Endosc. Epub ahead of print (1-6)

61.

Effect of thrombopoietin on platelet counts and liver regeneration after partial hepatectomy in a rat model. Shimabukuro R, et al. Surg Today 39(12):1054-1059,2009

62.

Effect of laparoscopic splenectomy on portal hypertensive gastropathy in cirrhotic patients with portal hypertension. Anegawa G, et al. J Gastroenterol Hepatol. 24(9):1554-1558,2009

CONTENTS PUBLICATIONS IN 2009 Page11

肺 63.

Prospective phase II study of gefitinib in non-small cell lung cancer with epidermal growth factor receptor gene mutations. Sugio K, et al. Lung Cancer 64(3):314-318,2009

64.

Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patients. Yano T, et al. Lung Cancer 63(1):111-114,2009

65.

Current status of pulmonary metastasectomy from primary epithelial tumors. Yano T, et al. Surg Today 39(2):91-97,2009

66.

Treatment after the failure of gefitinib in patients with advanced or recurrent non-small cell lung cancer. Maruyama R, et al. Anticancer Res. 29(10):4217-4221,2009

67.

Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer. Yamaguchi M, et al. Cancer Chemother Pharmacol. Epub ahead of print (1-6)

68.

Surgical resection transplantation.

of

pulmonary

malignant

tumors

after

living

donor

liver

Shoji F, et al. Ann Thorac Surg. 88(1):206-211,2009 69.

The dynamics and clinical significance of alpha 2 plasmin inhibitor-plasmin complex and thrombin-antithrombin complex in postoperative pleural effusion following a pulmonary lobectomy. Shoji F, et al. Surg Today 39(4):320-325,2009

70.

The perioperative complications for elderly patients with lung cancer associated with a pulmonary resection under general anesthesia. Suemitsu R, et al. J Thorac Oncol. 4(2):193-197,2009

CONTENTS PUBLICATIONS IN 2009 肺 71.

Page12

Benzo[a]pyrene promotes proliferation of human lung cancer cells by accelerating the epidermal growth factor receptor signaling pathway. Kometani T, et al. Cancer Lett. 278(1):27-33,2009

72.

Asymptomatic air embolism after computed tomography- guided lung needle marking. Tagawa T, et al. J Thorac Oncol. 4(7):937-938,2009

73.

Expression of an X-family DNA polymerase, pol lambda, in the respiratory epithelium of non-small cell lung cancer patients with habitual smoking. Ohba T, et al. Mutat Res. 677(1-2):66-71,2009

74.

Biological significance of the maximum standardized uptake values on positron emission tomography in non-small cell lung cancer. Takenaka T, et al. J Surg Oncol. 100(8):688-692,2009

75.

Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients. Takenaka T, et al. Lung Cancer 67(1):101-107,2010

76.

Long-term survival of a patient with type A thymoma and Masaoka's stage IV b: case report. Takenaka T, et al. Thorac Cardiovasc Surg. 57(8):496-497,2009

77.

Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression. Miura N, et al. Anticancer Res. 29(10):4099-4106,2009

78.

EGFR T790M mutation: a double role in lung cancer cell survival? Suda K, et al. J Thorac Oncol. 4(1):1-4,2009

CONTENTS PUBLICATIONS IN 2009 血管 79.

Page13

The involvement of aldosterone in cyclic stretch- mediated activation of NADPH oxidase in vascular smooth muscle cells. Ohmine T, et al. Hypertens Res. 32(8):690-699,2009